Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480060/805-50-25-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-2

Name:	us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Commitments and Contingencies (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Jun. 30, 2025
Other Commitments [Line Items]
Contingent payment		$ 0
Cerveau Technologies, Inc
Other Commitments [Line Items]
Asset acquisition, additional milestone payments	$ 51,000
Cerveau Technologies, Inc \| Sales Milestones
Other Commitments [Line Items]
Asset acquisition, additional milestone payments	1,200,000
Cerveau Technologies, Inc \| Research Revenue Milestones
Other Commitments [Line Items]
Asset acquisition, additional milestone payments	$ 13,500